Pamela Maher received her BSc from McGill University in Montreal, Quebec and her PhD from the University of British Columbia in Vancouver, British Columbia. She is currently a Senior Staff Scientist at The Salk Institute in La Jolla, CA. Her research interests include the characterization and development of natural products for the treatment of acute and chronic neurological disorders such as Alzheimer’s disease. In addition, she studies models and mechanisms of neuroprotection in neurodegenerative diseases.
Related Organizations
Articles from this author
September 17, 2025
[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...

